Karum Health Announced the appointment of former ConsumerMedical executive Randy K. Hawkins, MD, FACHE as the company’s Chief Medical Officer (CMO). With nearly three years of clinical experience as an anesthesiologist and senior health care technology director, Dr. Hawkins will advance Carrum’s mission of conducting rigorous analysis of providers and provider organizations, and expanding a world-class COE network nationwide .
Carrum’s COE partners represent the top 10% of their respective fields of expertise and are evaluated at the individual surgeon level. Through cooperation, Carrum COE is motivated to provide the most appropriate care in all situations, regardless of whether the patient has been recommended by another doctor for surgical intervention. This resulted in 30% of Carrum members being redirected to less invasive and lower cost care.
“As an anesthesiologist, I was fortunate to have affected the lives of many people, but I was ultimately attracted by the commercial aspect of healthcare, where I saw an opportunity to exert a greater influence to help restore the current model. This It involves aligning high-quality care with reasonable costs—while not ignoring the patient’s experience,” Hawkins said. “Carrum is the first company I have seen that seeks to solve the cost and quality components of the healthcare equation. Sach and his team have created a tool that provides true value-based care. The team’s talents and experience are in the industry. China is unparalleled. I am honored to join Carrum Health to provide our members with the highest quality and best care.”
Healthy mine The last webinar in their 3-part 2022 star webinar series will be held on Wednesday, November 17th. In this one-hour meeting, Healthmine’s industry experts will answer questions about current and new measures and share detailed insights on best practices for successful star rating in 2022. No questions are unrestricted!
Sign up for a live broadcast or receive on-demand recordings so you can watch them at your convenience.
To register, click here.
1upHealth Dr. Donald Rucker, the former National Health Information Technology Coordinator of the U.S. Department of Health and Human Services, has been hired as Chief Strategy Officer. 1upHealth has a Fast Healthcare Interoperability Resource (FHIR) platform for APIs. It connects payers, providers, patients, life sciences, and application developers in an interoperability network.
Earlier this year, the company Raised $25 million in Series B financing Led by F-Prime Capital. Existing investors Jackson Square Ventures, Eniac Ventures and Social Leverage also participated.
Ricky Sahu, CEO and founder of 1upHealth, said in a press release: “Dr. Rucker brings the unique perspective of the highest-level doctors, software engineers, product developers, and policy leaders. Few people in the world have With such a breadth of industry experience and understanding. As the father of the final rules of the ONC Cure Act, Dr. Rucker knows that this is only the first step-organizations need to go beyond just following the rules to get the most out of this transformative technology.”
To read more, click here.
Deep cureThe company that is using the world’s largest AI drug discovery engine to develop new small molecule therapies announced the completion of a US$40 million Series A financing. Morningside Ventures led this round of financing, and existing investors TLV Partners, Sapir Venture Partners and Benon Group Ltd participated in the round. To date, DeepCure has raised $47 million in funding. In addition to its AI-driven drug discovery platform and automated robotic laboratories, the company is also developing several new preclinical drug candidates in different “non-pharmacological” categories, from multi-pharmacology programs to protein-protein interactions, and The previously “impossible” specific challenges are critical to various fields. Indications for areas where medical needs are not met.
To read more, click here.
picture: Aquindo, Getty Images
